Chairman&CEO Sachiaki Ibe／President&COO Mitsuhiro Ibe
Zeria has two main business units:the Ethical Pharmaceuticals business arm and the Consumer Healthcare(OTC) business arm.Our Ethical Pharmaceuticals business has earned high acclaim from medical professionals for its gastrointestinal product lineup that covers conditions affecting both the upper and lower gastrointestinal tracts,led by Acofide and Asacol.
As means of putting into practice one of our corporate philosophies,"Reach out to the world,"Zeria is actively expanding global business development,and in fiscal 2015 our overseas sales to net sales ratio reached 20%.
Zeria will reinforce our foundation as a global company and strive to quickly realize the next goal of attaining an overseas sales to net sales ratio of 30%.
Going forward ,we will continue to pursue the highest quality for the products we provide and in all our corporate activities ,exceeding the expectations of our stakeholders.